NYSE:WSTLife Sciences
Leadership Shake-Up And Push For Independent Chair Might Change The Case For Investing In West (WST)
In March 2026, West Pharmaceutical Services announced that long-serving President, CEO and Board Chair Eric M. Green plans to retire in the second half of 2026, while a shareholder proposal from John Chevedden is pushing for the permanent separation of the CEO and Chair roles ahead of the May 4, 2026 annual meeting.
This combination of leadership transition and a call for an independent board chair brings the company’s governance framework into sharper focus for investors.
Next, we’ll...